Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Attovia Therapeutics
Attovia Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Attovia Therapeutics
Attovia Therapeutics Summary
Company Summary
Overview
Attovia Therapeutics is a biotechnology company that develops therapies for immune-mediated diseases. It utilizes ATTOBODY technology to generate biparatopic binders that provide an alternative to immunoglobulin G (IgG) based medicines.
Type
Private
Status
Active
Founded
2023
HQ
Fremont, CA, US
|
view all locations
Website
https://www.attovia.com
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
healthtech
platform
Homepage
Linkedin
Table of Contents
Key People
Locations
Competitors
Key People
Tao Fu,
Chief Executive Officer & Director
Linkedin
Hubert Chen,
Chief Medical Officer
Linkedin
Zaneta Odrowaz,
Chief Business Officer
Linkedin
Petter Veiby,
Chief Scientific Officer
Linkedin
and 2 others
Locations
View all
1 location detected
Fremont, CA
HQ
United States
47071 Bayside Pkwy, Suite 100
Competitors and Similar Companies
ENTEROME
Healthcare - Private
Anima Biotech
Healthcare - Private
Q32 Bio
Healthcare - Private
Totus Medicines
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top